About CNS Therapeutics
John Foster

John Foster

Chief Executive Officer
Co-Founder

Richard Penn, M.D.

Richard Penn, M.D.

Chief Scientific Officer
Co-Founder

Andy LaFrence

Andy LaFrence

Chief Financial Officer

Thomas Prentice

Thomas Prentice

Vice President
Technical Affairs

Michael Post

Michael Post

Vice President
Marketing

David Youngberg

David Youngberg

Vice President
Sales

Scott Bronson

Scott Bronson

Administration & Compliance Officer
Co-Founder

Jennifer Donovan

Jennifer Donovan

Director
Sales Operations

John Foster

Chief Executive Officer
Co-Founder

John Foster has more than 25 years of executive management expertise in developing and bringing biotechnology, pharmaceuticals and medical devices to market. Before founding CNS Therapeutics with Dr. Penn and Mr. Bronson, Mr. Foster was senior vice president of commercial operations at Restore Medical, which made its initial public offering in 2006 and was later acquired by Medtronic. Prior to that, he held key management positions with Advanced Respiratory, Medtronic's Neuromodulation business, and Genentech, a pioneer in biotechnology. Mr. Foster has a B.A. in history and business from Oral Roberts University and completed the University of Minnesota Executive Development program.

Richard Penn, M.D.

Chief Scientific Officer
Co-Founder

Richard Penn, M.D. has more than 30 years of experience practicing neurosurgery and is well known for his research and clinical work in drug delivery to the nervous system and surgical treatments for movement disorders. He pioneered the use of implanted drug pumps to deliver medications directly to the spinal cord, implanting the first programmable pump for cancer pain and developing intrathecal baclofen for spasticity. Dr. Penn also has contributed to the treatment of movement disorders with early studies on neuro-transplantation for Parkinson's disease and Huntington's disease. He was one of the first neurosurgeons in the United States to use deep brain stimulation for tremor and has extensive experience with stimulation of other brain sites to relieve bradykinesia and dystonia.

In addition to his role as co-founder at CNS Therapeutics, Dr. Penn is a professor of neurosurgery at Rush University Medical Center and an adjunct professor of bioengineering at the University of Illinois at Chicago. Dr. Penn graduated from Columbia College of Physicians and Surgeons in New York, NY.

Andy LaFrence

Chief Financial Officer

Andy LaFrence has over 25 years of financial and management experience. Prior to CNS Therapeutics he was an audit partner at KPMG LLP where he focused on supporting venture backed, high growth medical technology, pharmaceutical, biotech and clean tech private and public companies. Mr. LaFrence is a certified public accountant and has a B.S. in accounting and a minor in Business Administration from the Illinois State University.

Thomas Prentice

Vice President
Technical Affairs

Thomas Prentice has 25 years of broad-based experience in design and manufacturing engineering, project management, quality systems and global supply chain expertise. Prior to joining CNS Therapeutics, Mr. Prentice held numerous management positions with Medtronic in global leadership of manufacturing IT, supply chain and manufacturing. Mr. Prentice has a B.S. in mechanical engineering and an MSMOT from the University of Minnesota.

Michael Post

Vice President
Marketing

Michael Post has 15 years of experience in the health care and consulting industry. Before joining CNS Therapeutics, he held key sales and marketing positions at Eli Lilly in areas including brand development, product launches, market research, lifecycle management, business development and sales management. Prior to that, he worked at Arthur Andersen in the corporate recovery consulting group. Mr. Post has a B.S. from Miami University and a MBA from the University of Michigan.

David Youngberg

Vice President
Sales

David Youngberg has 15 years of successful sales and sales management experience in the medical device market and has held numerous key sales positions at Medtronic and Restore Medical. He has been in sales and management for Horizon Medical Products and Ethicon Endo-Surgery business. Before his career in medical sales, he was an officer of the United States Navy. Mr. Youngberg has a B.A. in economics from the University of Minnesota.

Scott Bronson

Administration & Compliance Officer
Co-Founder

Scott Bronson has 37 years of financial experience in the medical device field. As Co-Founder of CNS Therapeutics with Dr. Penn and Mr. Foster, he served as CFO from inception to January, 2011. Previously he held key financial positions at Medtronic including vice president of finance for global business services, the neurological and diabetes sector and the interventional vascular sector. Prior to Medtronic, he held various accounting positions with TSI, Inc. Mr. Bronson is a certified management accountant and has a B.S.B. in accounting and a MBA in finance from the University of Minnesota.

Jennifer Donovan

Director
Sales Operations

Jennifer Donovan has more than 10 years of experience in the life sciences industry. Before joining CNS Therapeutics, she led U.S. and global information technology projects as part of Medtronic's Global Information Technology Department. Prior to that, she provided sales support and inventory management for Medtronic's Cardiac Rhythm Management sales force. Ms. Donovan has a B.A. in biology from Gustavus Adolphus College in St. Peter, Minn.